These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 24373218

  • 1. Carprofen inhibits the release of matrix metalloproteinases 1, 3, and 13 in the secretome of an explant model of articular cartilage stimulated with interleukin 1β.
    Williams A, Smith JR, Allaway D, Harris P, Liddell S, Mobasheri A.
    Arthritis Res Ther; 2013; 15(6):R223. PubMed ID: 24373218
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation.
    Clutterbuck AL, Mobasheri A, Shakibaei M, Allaway D, Harris P.
    Ann N Y Acad Sci; 2009 Aug; 1171():428-35. PubMed ID: 19723086
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High throughput proteomic analysis of the secretome in an explant model of articular cartilage inflammation.
    Clutterbuck AL, Smith JR, Allaway D, Harris P, Liddell S, Mobasheri A.
    J Proteomics; 2011 May 01; 74(5):704-15. PubMed ID: 21354348
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of low molecular weight hyaluronan combined with carprofen on canine osteoarthritis articular chondrocytes and cartilage explants in vitro.
    Euppayo T, Siengdee P, Buddhachat K, Pradit W, Viriyakhasem N, Chomdej S, Ongchai S, Harada Y, Nganvongpanit K.
    In Vitro Cell Dev Biol Anim; 2015 Sep 01; 51(8):857-65. PubMed ID: 25982358
    [Abstract] [Full Text] [Related]

  • 8. Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes.
    Dunn SL, Wilkinson JM, Crawford A, Le Maitre CL, Bunning RA.
    Osteoarthritis Cartilage; 2014 Jan 01; 22(1):133-44. PubMed ID: 24211233
    [Abstract] [Full Text] [Related]

  • 9. In vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and carprofen.
    Frean SP, Abraham LA, Lees P.
    Res Vet Sci; 1999 Oct 01; 67(2):183-90. PubMed ID: 10502490
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants.
    Stevens AL, Wheeler CA, Tannenbaum SR, Grodzinsky AJ.
    Osteoarthritis Cartilage; 2008 Apr 01; 16(4):489-97. PubMed ID: 17923423
    [Abstract] [Full Text] [Related]

  • 11. Clusterin secretion is attenuated by the proinflammatory cytokines interleukin-1β and tumor necrosis factor-α in models of cartilage degradation.
    Matta C, Fellows CR, Quasnichka H, Williams A, Jeremiasse B, Allaway D, Mobasheri A.
    J Orthop Res; 2021 May 01; 39(5):1017-1029. PubMed ID: 32725904
    [Abstract] [Full Text] [Related]

  • 12. A sodium dodecyl sulfate-polyacrylamide gel electrophoresis-liquid chromatography tandem mass spectrometry analysis of bovine cartilage tissue response to mechanical compression injury and the inflammatory cytokines tumor necrosis factor alpha and interleukin-1beta.
    Stevens AL, Wishnok JS, Chai DH, Grodzinsky AJ, Tannenbaum SR.
    Arthritis Rheum; 2008 Feb 01; 58(2):489-500. PubMed ID: 18240213
    [Abstract] [Full Text] [Related]

  • 13. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, Caterson B.
    Biochem J; 1999 Nov 15; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the catabolic effects of interleukin-1beta on proteoglycan metabolism in equine cartilage cocultured with synoviocytes.
    Gregg AJ, Fortier LA, Mohammed HO, Mayr KG, Miller BJ, Haupt JL.
    Am J Vet Res; 2006 Jun 15; 67(6):957-62. PubMed ID: 16740087
    [Abstract] [Full Text] [Related]

  • 15. Effects of equine recombinant interleukin-1alpha and interleukin-1beta on proteoglycan metabolism and prostaglandin E2 synthesis in equine articular cartilage explants.
    Takafuji VA, McIlwraith CW, Howard RD.
    Am J Vet Res; 2002 Apr 15; 63(4):551-8. PubMed ID: 11939318
    [Abstract] [Full Text] [Related]

  • 16. Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes.
    Tung JT, Fenton JI, Arnold C, Alexander L, Yuzbasiyan-Gurkan V, Venta PJ, Peters TL, Orth MW, Richardson DW, Caron JP.
    Can J Vet Res; 2002 Jan 15; 66(1):19-25. PubMed ID: 11858644
    [Abstract] [Full Text] [Related]

  • 17. Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1β-treated articular cartilage.
    Clutterbuck AL, Allaway D, Harris P, Mobasheri A.
    F1000Res; 2013 Jan 15; 2():147. PubMed ID: 24555068
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1β and tumor necrosis factor α.
    Terkeltaub R, Yang B, Lotz M, Liu-Bryan R.
    Arthritis Rheum; 2011 Jul 15; 63(7):1928-37. PubMed ID: 21400477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.